Volume 20, Number 1—January 2014
Research
Dynamic Modeling of Cost-effectiveness of Rotavirus Vaccination, Kazakhstan
Table 3
Estimates of projected direct and indirect costs associated with rotavirus disease and rotavirus vaccination, Kazakhstan
Item (per case) |
Cost estimates in 2012 US dollars |
|||
Direct |
Indirect |
Total |
Reference/source |
|
Rotavirus death | 543.33 | 67,254.13 | 67,799.46 | (8) |
Severe case (inpatient care) | 364.36 | 181.47 | 545.83 | (8) |
Moderate case (outpatient care) | 32.43 | 65.57 | 98.00 | (8) |
Mild case (homecare) | 3.49 | 21.86 | 25.35 | (8) |
Cost of vaccine per dose, base case | 43.00 | 0 | 43.00 | Authors’ assumption |
Cold chain upgrade (total first year) | 237,300 | 0 | 237,300 | KMoH |
Training costs (first year) | 120,096 | 0 | 120,096 | KMoH |
Annual cost of cold chain and training |
22,037.74 |
0 |
22,037.74 |
KMoH |
*KMoH, Kazakh Ministry of Health. |